Binding of the 7SK snRNA turns the HEXIM1 protein into a P-TEFb (CDK9/cyclin T) inhibitor

被引:246
作者
Michels, AA
Fraldi, A
Li, Q
Adamson, TE
Bonnet, F
Nguyen, VT
Sedore, SC
Price, JP
Price, DH
Lania, L
Bensaude, O
机构
[1] Ecole Normale Super, CNRS, Lab Regulat Express Genet, CNRS,UMR 8541, F-75230 Paris 05, France
[2] Univ Naples Federico II, Dipartimento Genet Biol Gen & Mol, Naples, Italy
[3] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA
[4] Univ Iowa, Med Scientist Training Program, Iowa City, IA USA
关键词
HEXIM1; MAQ1; P-TEFb; RNA polymerase II; transcription;
D O I
10.1038/sj.emboj.7600275
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The positive transcription elongation factor b (P-TEFb) plays a pivotal role in productive elongation of nascent RNA molecules by RNA polymerase II. Core active P-TEFb is composed of CDK9 and cyclin T. In addition, mammalian cell extracts contain an inactive P-TEFb complex composed of four components, CDK9, cyclin T, the 7SK snRNA and the MAQ1/HEXIM1 protein. We now report an in vitro reconstitution of 7SK-dependent HEXIM1 association to purified P-TEFb and subsequent CDK9 inhibition. Yeast three-hybrid tests and gel-shift assays indicated that HEXIM1 binds 7SK snRNA directly and a 7SK snRNA-recognition motif was identified in the central part of HEXIM1 (amino acids (aa) 152-155). Data from yeast two-hybrid and pull-down assay on GST fusion proteins converge to a direct binding of P-TEFb to the HEXIM1 C-terminal domain (aa 181-359). Consistently, point mutations in an evolutionarily conserved motif (aa 202-205) were found to suppress P-TEFb binding and inhibition without affecting 7SK recognition. We propose that the RNA-binding domain of HEXIM1 mediates its association with 7SK and that P-TEFb then enters the complex through association with HEXIM1.
引用
收藏
页码:2608 / 2619
页数:12
相关论文
共 31 条
[11]   MAQ1 and 7SK RNA interact with CDK9/cyclin T complexes in a transcription-dependent manner [J].
Michels, AA ;
Nguyen, VT ;
Fraldi, A ;
Labas, V ;
Edwards, M ;
Bonnet, F ;
Lania, L ;
Bensaude, O .
MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (14) :4859-4869
[12]   7SK small nuclear RNA binds to and inhibits the activity of CDK9/cyclin T complexes [J].
Nguyen, VT ;
Kiss, TS ;
Michels, AA ;
Bensaude, O .
NATURE, 2001, 414 (6861) :322-325
[13]   Suppression of NF-κB-dependent gene expression by a hexamethylene bisacetamide-inducible protein HEXIM1 in human vascular smooth muscle cells [J].
Ouchida, R ;
Kusuhara, M ;
Shimizu, N ;
Hisada, T ;
Makino, Y ;
Morimoto, C ;
Handa, H ;
Ohsuzu, F ;
Tanaka, H .
GENES TO CELLS, 2003, 8 (02) :95-107
[14]   Mechanisms of cyclin-dependent kinase regulation: Structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors [J].
Pavletich, NP .
JOURNAL OF MOLECULAR BIOLOGY, 1999, 287 (05) :821-828
[15]   Identification of multiple cyclin subunits of human P-TEFb [J].
Peng, JM ;
Zhu, YR ;
Milton, JT ;
Price, DH .
GENES & DEVELOPMENT, 1998, 12 (05) :755-762
[16]   DSIF and NELF interact with RNA polymerase II elongation complex and HIV-1 Tat stimulates P-TEFb-mediated phosphorylation of RNA polymerase II and DSIF during transcription elongation [J].
Ping, YH ;
Rana, TM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (16) :12951-12958
[17]   P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II [J].
Price, DH .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (08) :2629-2634
[18]   A highly purified RNA polymerase II elongation control system [J].
Renner, DB ;
Yamaguchi, Y ;
Wada, T ;
Handa, H ;
Price, DH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (45) :42601-42609
[19]   Activation and function of cyclin T-Cdk9 (positive transcription elongation factor-b) in cardiac muscle-cell hypertrophy [J].
Sano, M ;
Abdellatif, M ;
Oh, H ;
Xie, M ;
Bagella, L ;
Giordano, A ;
Michael, LH ;
DeMayo, FJ ;
Schneider, MD .
NATURE MEDICINE, 2002, 8 (11) :1310-1317
[20]   CDK-9/cyclin T (P-TEFb) is required in two postinitiation pathways for transcription in the C-elegans embryo [J].
Shim, EY ;
Walker, AK ;
Shi, Y ;
Blackwell, TK .
GENES & DEVELOPMENT, 2002, 16 (16) :2135-2146